Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents Labiotech.eu
Update (28/01/2019): MorphoSys faces defeat in its long-running legal battle with Genmab and Janssen, as the US District Court of Delaware has declared three …